Proteasomal machinery degrades death receptors, and selective inhibition of proteasomal degradation pathway has been shown to have potent antitumor effect in many cancer types.35, 36 With an objective to have sustained expression of Fas on the cell surface of target cells, we pretreated cervical cancer cells with MG132. The gene discussed is FAS; the disease is cervical carcinoma.